Cite
HARVARD Citation
Arthur, C. et al. (2020). Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. Leukemia & lymphoma. 61 (4), pp. 831-839. [Online].